Tech Company Financing Transactions

Claris Bio Funding Round

Catalio Capital Management, Samsara BioCapital and Adage Capital Management participated in a $118 million Series B funding round for Claris Bio. The funding round was announced on 7/28/2026.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

299 Pavonia Avenue 3-8
Jersey City, NJ 07302
USA

Phone

Undisclosed

Website

www.clarisbio.com

Email Address

Not Recorded

Overview

Claris is pioneering solutions for patient populations struggling with sight-threatening corneal diseases. Claris Biotherapeutics, licensing intellectual property from Massachusetts Eye and Ear Infirmary (MEEI) and accessing drug substance in an agreement with partner Kringle Pharma.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Clarke Atwell

        

Chief Medical Officer

Susan Orr

        

VP - Bus. Development

Henry Rath

        

Browse more venture capital transactions:

Prev: 7/28/2026: Epitel venture capital transaction
Next: 7/28/2026: Conversica venture capital transaction

Share this article

Where The Data Comes From

We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary